Purchase this article with an account.
M.E. Mulet, J.L. Alio, M. Mahiques, J.I. Belda, J.M. Martin; ADAL–1TM Adhesive for Strabismus Surgery: Clinical Trial . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2960.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To evaluate the efficacy and biotolerance of the Adal–1TM adhesive for muscle sealing in strabismus surgery.Methods: 27 eyes were included in the study, 17 in the control group and 10 in the study group in which surgery was performed on the horizontal rectus muscles. In the control group the muscle was joined to the sclera by vicrylTM 7/0 suture and in the study group by Adal–1TM adhesive. The efficacy of the sealing of the muscle to the sclera was evaluated and the biotolerance of the surrounding tissues.Results: The muscular resection in the control group was 8,17±2,38 with displacement of the sealing point of 0,02 ±1,7 mm. In the group sealed with adhesive the muscular resection was 9,09 ± 3,08 with displacement of 0,15 ± 1,56 mm. There were no significant differences P< 0,05 between the techniques. The inflammation of the surrounding tissues in the immediate postoperative period was greater in the suture technique with a value of P>0,05 but there were no differences in the other post operative periods. (U–Man–Whitney).Conclusions: ADAL–1TM is an effective and safe alternative for strabismus surgery
This PDF is available to Subscribers Only